Bartoli, F.; Riboldi, I.; Bachi, B.; Calabrese, A.; Moretti, F.; Crocamo, C.; Carrà, G.
Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review. J. Clin. Med. 2021, 10, 1303.
https://doi.org/10.3390/jcm10061303
AMA Style
Bartoli F, Riboldi I, Bachi B, Calabrese A, Moretti F, Crocamo C, Carrà G.
Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review. Journal of Clinical Medicine. 2021; 10(6):1303.
https://doi.org/10.3390/jcm10061303
Chicago/Turabian Style
Bartoli, Francesco, Ilaria Riboldi, Bianca Bachi, Angela Calabrese, Federico Moretti, Cristina Crocamo, and Giuseppe Carrà.
2021. "Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review" Journal of Clinical Medicine 10, no. 6: 1303.
https://doi.org/10.3390/jcm10061303
APA Style
Bartoli, F., Riboldi, I., Bachi, B., Calabrese, A., Moretti, F., Crocamo, C., & Carrà, G.
(2021). Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review. Journal of Clinical Medicine, 10(6), 1303.
https://doi.org/10.3390/jcm10061303